From June 9, 2022 to June 22, 2023, the company has repurchased 634,881 shares, representing 0.4% for AUD 1.28 million. With this, the company has completed the repurchase of 634,881 shares, representing 0.4% for AUD 1.28 million under the buyback announced on June 9, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.55 AUD | -6.06% | +23.02% | +84.52% |
26/03 | Race Oncology Obtains Certificate of Analysis for RC220; Shares Up Almost 6% | MT |
18/03 | Race Oncology Limited(ASX:RAC) dropped from S&P/ASX All Ordinaries Index | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+84.52% | 17Cr | |
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-10.86% | 1.7TCr | |
+5.10% | 1.37TCr | |
+37.57% | 1.24TCr |
- Stock Market
- Equities
- RAC Stock
- News Race Oncology Limited
- Tranche Update on Race Oncology Limited's Equity Buyback Plan announced on June 9, 2022.